10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

5 Big Financial Stocks to Boost Your Gains in September

09.16.14 | 10:05 AM

BALTIMORE (Stockpickr) -- Did you notice the subtle shift in stocks at the beginning of the summer? It was easy to miss, but grabbing hold of the n...

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

09.16.14 | 09:20 AM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter